Stockholm3

DIAGNOSTIC_TEST3 trials

Sponsors

University Hospital, Basel, Switzerland, Karolinska Institutet, Insel Gruppe AG, University Hospital Bern

Conditions

Active Surveillance for Prostate CancerLocalized CarcinomaProstate Cancer

Unknown Phase

Validation of the Stockholm3 Test for Detection of Prostate Cancer in the Swiss Population

CompletedNCT05294627

University Hospital, Basel, SwitzerlandLocalized Carcinoma, Prostate Cancer

Start: 2020-01-01End: 2023-10-01Updated: 2023-12-12

Stockholm3 Use Prior to MRI for Prostate Cancer Detection in a Clinical Care Pathway: a Multi-centered Validation

Not yet recruitingNCT06573736

Karolinska InstitutetProstate Cancer

Start: 2024-10-01End: 2025-12-31Target: 500Updated: 2024-08-27

Stockholm3 Test Validation in Men on Active Surveillance in Switzerland (CHAS3 Trial)

Not yet recruitingNCT07478536

Insel Gruppe AG, University Hospital BernActive Surveillance for Prostate Cancer, Prostate Cancer

Start: 2026-07-01End: 2028-08-31Target: 350Updated: 2026-06-22